United Therapeutics

United Therapeutics is one of the...

• Russell 3000.

United Therapeutics is a company listed under the stock ticker UTHR (US).

View the org chart displaying its 15 main executives

Most searched biographies at United Therapeutics

• Martine Rothblatt, Chairman of the Board and Chief Executive Offic...
• Raymond Dwek, Director
• Raymond Kurzweil, Director

Create an alert
to follow the executive moves at United Therapeutics.

United Therapeutics has 1,899 competitors including Neptune Wellness Solutions (Canada), Eurofins (Luxembourg) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Moma Therapeutics has just announced a $150 Million fundraising. (posted on May 12 2022).
• Absolute has just announced a $100 Million fundraising. (posted on May 9 2022).
• Redcliffe Genetics has just announced a $61 Million fundraising. (posted on May 9 2022).

Popular contacts in Biotechnology

• Daniel Schmachtenberger - Director of Research and Development at Neurohacker Collective
• Franz-Werner Haas - Chief Executive Officer at CureVac
• Heiko Von Der Leyen - Medical Director at Orgenesis

Learn more about the Biotechnology industry >

Press releases by United Therapeutics

• News | United Therapeutics Corporation
• Press Releases | United Therapeutics Corporation
• United Therapeutics Corporation Reports 2018 Fourth Quarter And Annual Financial Results | United Therapeutics Corporation
• United Therapeutics Corporation To Report Fourth Quarter And Annual 2018 Financial Results Before The Market Opens On Wednesday, February 27, 2019 | United Therapeutics Corporation
• Survival Data From FREEDOM-EV Study of Orenitram Presented at the Pulmonary Vascular Research Institute Annual World Congress | United Therapeutics Corporation
• United Therapeutics Announces Closing Of License Agreement With Arena Pharmaceuticals For Ralinepag | United Therapeutics Corporation
• United Therapeutics Corporation To Present At 37th Annual J.P. Morgan Healthcare Conference | United Therapeutics Corporation
• Press Releases | United Therapeutics Corporation
• Health Canada Approves Unituxin® For The Treatment Of Pediatric High-Risk Neuroblastoma | United Therapeutics Corporation
• Arena Pharmaceuticals and United Therapeutics Announce Global License Agreement for Ralinepag | United Therapeutics Corporation
• View more press releases Close

Social media about United Therapeutics

• United Therapeutics on Wikipedia, Google News & Yahoo Finance
• United Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Martine Rothblatt

Call United Therapeutics at +1 301...

View the org chart

Register to receive your alert

Report an error